BD Board Declares Dividend

News provided by

Nov 23, 2015, 05:25 ET

FRANKLIN LAKES, N.J., Nov. 23, 2015 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.66 cents per common share, an increase of 10.0 percent from the previous quarter. The dividend will be payable on December 31, 2015 to holders of record on December 10, 2015. The indicated annual dividend rate for fiscal year 2016 is $2.64 per share.

"Fiscal 2015 was a significant year for BD with the successful completion of the largest acquisition in the Company's history. We are very proud of our strong fiscal 2015 results, and we have entered fiscal 2016 with continued confidence in our ability to execute our strategy," said Vincent A. Forlenza, Chairman, CEO and President. "This is the forty-fourth consecutive fiscal year in which we have raised our dividend. This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to our shareholders."

About BD

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.

Contact:
Kristen Cardillo, Corporate Communications – 858-617-2317
Monique Dolecki, Investor Relations – 201-847-5378

SOURCE BD (Becton, Dickinson and Company)